Loading...

RBC Lysis Buffer (10X)

Pricing & Availability
Regulatory Status
RUO
Other Names
Red blood cell lysis buffer
Ave. Rating
Submit a Review
Product Citations
publications
Cat # Size Price Quantity Check Availability Save
420301 100 mL 52€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
420302 500 mL 165€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Red Blood Cell (RBC) Lysis Buffer has been designed, formulated, and tested to ensure optimal lysis of RBCs in single cell suspensions with minimal effects on leukocytes. RBC Lysis Buffer is supplied as a 10X solution containing ammonium chloride, potassium carbonate, and EDTA, and should be diluted in deionized water prior to use. Nucleated RBCs are not effectively lysed with ammonium chloride. Test

Product Details
Technical Data Sheet (pdf)

Product Details

Formulation
This red blood cell (RBC) lysis buffer is supplied as a 10X solution and should be diluted to 1X in deionized water. 100 ml of 10X concentrate will yield a quantity of 1X solution that is sufficient to lyse 500 samples.
Preparation
The pH of the 1X solution should fall within the range of pH 7.1-7.4. Adjust the pH if necessary. Warm the 1X solution to room temperature prior to use.
Storage & Handling
Store RBC lysis buffer between 2°C and 8°C.
Application Notes

A. Lysis of Mouse Spleen RBCs:
1. Harvest mouse spleen and prepare a single cell suspension.
2. Pellet the cells by centrifugation (350 x g); aspirate the supernatant.
3. Dilute the 10X Red Blood Cell Lysis Buffer to 1X working concentration with deionized water and resuspend the pellet in 5 ml of 1X Lysis Buffer.
4. Incubate on ice for 4-5 minutes with occasional shaking.
5. Stop the reaction by diluting the Lysis Buffer with 20-30 ml of 1X PBS.
6. Spin the cells (350 x g) and discard the supernatant.
7. Resuspend the pellet in the appropriate buffer (e.g., BioLegend Cell Staining Buffer Cat. No. 420201), wash 1X.
8. Count cells, adjust density, and proceed with cell staining procedures.
B. Lysis of Human Peripheral Blood RBCs:
1. Dilute the 10X RBC Lysis Buffer to 1X working concentration with deionized water. Warm the 1X solution to room temperature prior to use.
2. Add 2.0 ml of 1X RBC Lysis Buffer to each tube containing up to 100 µl of whole blood.
3. Gently vortex each tube immediately after adding the lysing solution. Incubate at room temperature, protected from light, for 10-15 minutes.
4. Centrifuge 350 x g for 5 minutes. Aspirate supernatant without disturbing pellet.
5. Resuspend the pellet in the appropriate buffer (e.g., BioLegend Cell Staining Buffer, Cat. No. 420201), wash 1X.
6. Resuspend and proceed with further procedures.

Application References
  1. Adams RA, et al. 2007. J. Exp. Med. 204:571.
  2. Feild-Corbett C, et al. 2009. Stem Cells. PubMed
  3. de Resende MM, et al. 2010. Physiol Genomics. 42:437. PubMed
  4. Roybal JD, et al. 2011. Mol Cancer Res. 9:25. PubMed
  5. Boldin MP, et al. 2011. J Exp Med. PubMed
  6. Kahlenberg JM, et al. 2011. J. Immunol. 187:6143. PubMed
  7. Deiuliis JA, et al. 2012. Am J Physiol Lung Cell Mol Physiol. 302:399. PubMed
  8. Wu CY, et al. 2012. PLoS One. 7:e42365. PubMed
  9. Hsia BJ, et al. 2012. J Allergy Clin Immunol. 130:205. PubMed
  10. Rico C, et al. 2012. Carcinogenesis. 33:2283. PubMed
  11. Jin J, et al. 2012. Arterioscler Thromb Vasc Biol. 32:2901. PubMed
  12. Saraiva AM, 2013. Hum Immunol. 74:207. PubMed
  13. Koon HW, et al. 2013. J Vis exp. 68:4208. PubMed
  14. Ma Dy, et al. 2013. J Virol. 87:3361. PubMed
  15. Han W, 2013. J. Immunol. 190:4786. PubMed
  16. Garcia-Acros I, et al. 2013. J Biol Chem. 288:14046. PubMed
  17. Zhao JL, et al. 2013. Elife. 21:537. PubMed
  18. Guo W, et al. 2013. J Gerontol A Biol Sci Med Sci. PubMed
  19. Yamasaki S, et al. 2013. Clin Vaccine immunol. 20:1508. PubMed
  20. Kraft P, et al. 2013. Stroke. 44:3202. PubMed
  21. Liu X, et al. 2013. Invest Ophthalmol Vis Sci. 54:7386. PubMed
  22. Fullerton AM, et al. 2013. Toxicol Sci. 136:72. PubMed
  23. Cekic C, et al. 2013. J Exp Med. 210:2693. PubMed
  24. Varga T, et al. 2013. J. Immunol. 191:5695. PubMed
  25. Ma Y, et al. 2014. Cancer Res. 74:436. PubMed
  26. Chang YJ, et al. 2014. Cytotherapy. 16:560. PubMed
  27. Kim MJ, et al. 2014. Mol Pharmacol. 86:284. PubMed
  28. Cekic C, et al. 2014. Cancer Res. 74:7250. PubMed
  29. Szulzewsky F, et al. 2015. PloS One. 10:116644. PubMed
Product Citations
  1. Shah D, et al. 2021. Oncoimmunology. 10:1939601. PubMed
  2. Hutton C, et al. 2021. Cancer Cell. 39:1227. PubMed
  3. Sandovici I, et al. 2022. Dev Cell. 57:63. PubMed
  4. Rathakrishnan A, et al. 2020. Viruses. 12: . PubMed
  5. Wang Y, et al. 2021. Cancer Res. 81:384. PubMed
  6. Wang H, et al. 2022. Nat Biomed Eng. 6:882. PubMed
  7. Yeh PY, et al. 2022. Sens Actuators B Chem. 353: . PubMed
  8. Ammothumkandy A, et al. 2022. Nat Neurosci. 25:493. PubMed
  9. Melendez E, et al. 2022. Development. 149: . PubMed
  10. Argueta LB, et al. 2022. iScience. 25:104223. PubMed
  11. Wang S, et al. 2022. Adv Sci (Weinh). 9:e2201258. PubMed
  12. Meena AS, et al. 2022. Cell Rep. 39:110937. PubMed
  13. Zhang Y, et al. 2022. Vaccines (Basel). 10: . PubMed
  14. Sugimoto S, et al. 2022. Nat Metab. 4:775. PubMed
  15. Moore AR, et al. 2022. Cell Rep. 41:111651. PubMed
  16. Isildar B, et al. 2022. Inflamm Regen. 42:55. PubMed
  17. Xu Q, et al. 2022. Front Med (Lausanne). 9:940554. PubMed
  18. Alexandrou AT, et al. 2022. iScience. 25:105546. PubMed
  19. Wang Y, et al. 2022. Front Endocrinol (Lausanne). 13:1036517. PubMed
  20. He Y, et al. 2022. Front Immunol. 13:986202. PubMed
  21. Tratwal J, et al. 2022. Front Endocrinol (Lausanne). 13:1001210. PubMed
  22. Xie Z, et al. 2022. Cell Discov. 8:133. PubMed
  23. Xiang X, et al. 2022. Medicine (Baltimore). 101:e32558. PubMed
  24. Yu Z, et al. 2023. Cancer Res. 83:700. PubMed
  25. Ding D, et al. 2023. J Med Chem. 66:1467. PubMed
  26. Oh S, et al. 2023. Nat Biotechnol. :. PubMed
  27. Marritt KL, et al. 2023. Front Immunol. 13:1087991. PubMed
  28. He T, et al. 2023. Immun Inflamm Dis. 11:e759. PubMed
  29. Vyas M, et al. 2023. Front Immunol. 13:1098445. PubMed
  30. Li XF, et al. 2023. J Exp Med. 220: . PubMed
  31. Wang J, et al. 2023. Inflamm Regen. 43:12. PubMed
  32. Ma Y, et al. 2022. Am J Physiol Heart Circ Physiol. 322:H622. PubMed
  33. Feng J, et al. 2022. Immunity. 55:405. PubMed
  34. Rustagi Y, et al. 2022. Diabetes. 71:1149. PubMed
  35. Dobie R, et al. 2020. Cell Reports. 29(7):1832-1847.e8.. PubMed
  36. Strickley JD, et al. 2019. Nature. 575:519. PubMed
  37. Deiuliis J, et al. 2012. Am J Physiol Lung Cell Mol Physiol. 302:L399. PubMed
  38. Jin J, et al. 2012. Arterioscler Thromb Vasc Biol. 32:2901. . PubMed
  39. Barros-Martins J, et al. 2016. J Immunol. 196: 3642 - 3652. PubMed
  40. Zhou B, et al. 2020. Nat Immunol. 1.868055556. PubMed
  41. Tan J, et al. 2021. iScience. 24(8):102835. PubMed
  42. Asem M, et al. 2020. Cancer Res. 1156:80. PubMed
  43. Lin C, et al. 2020. Cancer Immunol Res. 632:8. PubMed
  44. Tsai AG, et al. 2020. Nat Med. 408:26. PubMed
  45. Guennoun R, et al. 2022. Cancers (Basel). 14:. PubMed
  46. Zhuo Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  47. Knelson EH, et al. 2022. Cancer Immunol Res. 10:947. PubMed
  48. Wakiyama H, et al. 2022. Cancer Immunol Res. 10:1386. PubMed
  49. Roweth HG, et al. 2022. Sci Adv. 8:eabo5224. PubMed
  50. Zhong J, et al. 2022. J Adv Res. 41:145. PubMed
  51. Yun HJ, et al. 2022. Int J Mol Sci. 23:. PubMed
  52. Daum P, et al. 2023. Front Immunol. 13:991347. PubMed
  53. Rao D, et al. 2023. Eur J Immunol. 53:e2250258. PubMed
  54. Le DT, et al. 2023. iScience. 26:106059. PubMed
  55. Romo-Rodríguez R, et al. 2023. Arch Med Res. 54:197. PubMed
  56. Mabire M, et al. 2023. Nat Commun. 14:1830. PubMed
  57. MacPherson KP, et al. 2023. Front Cell Neurosci. 17:895017. PubMed
  58. Chen Z, et al. 2023. Nat Commun. 14:1839. PubMed
  59. Martins Nascentes Melo L, et al. 2023. J Immunother Cancer. 11:. PubMed
  60. Ramalingam P, et al. 2023. Nat Commun. 14:2018. PubMed
  61. Choi YJ, et al. 2023. Nat Commun. 14:2045. PubMed
  62. He Q, et al. 2023. Parasit Vectors. 16:139. PubMed
  63. Pattnaik A, et al. 2023. Vaccines (Basel). 11:. PubMed
  64. Mulcrone PL, et al. 2023. Sci Rep. 13:8436. PubMed
  65. Villalba N, et al. 2023. J Neuroinflammation. 20:127. PubMed
  66. Song S, et al. 2023. Bioact Mater. 28:358. PubMed
  67. Matsudaira T, et al. 2023. Commun Biol. 6:665. PubMed
  68. Nguyen, H. P., An, K., et al. 2025. Nat Biotechnol. 43(12),1979-1995. PubMed
  69. Jebbawi, F., Olomski, F., et al. 2025. Allergy. 80(12),3377-3390. PubMed
  70. Xu, L., Paine, A. C., et al. 2025. J Virol. 99(10),e0126125. PubMed
  71. Haykal, T., Yang, R., et al. 2025. Cancer Res. 85(24),4995-5014. PubMed
  72. Li, S., Wang, Y., et al. 2025. Signal Transduct Target Ther. 10(1),323. PubMed
  73. Huang, H., Li, S., et al. 2025. Sci Rep. 15(1),35547. PubMed
  74. Li, Q., de Oliveira Formiga, R., et al. 2025. Nat Metab. 7(12),2510-2530. PubMed
  75. Phoon, Y. P., Wolfarth, A. A., et al. 2025. Sci Rep. 15(1),37950. PubMed
  76. Choi, Y., Shim, M., et al. 2025. Exp Mol Med. 57(11),2487-2504. PubMed
  77. Chen, Y., Liao, Y., et al. 2025. Nat Commun. 16(1),10249. PubMed
  78. Han, C., Yuan, H., et al. 2025. FASEB J. 39(23),e71273. PubMed
  79. Wessel, B. M., Castro, J. N., et al. 2025. Organoids. 4(4),0. PubMed
  80. Qiu, Z., Song, N. J., et al. 2025. J Clin Invest. 0(0),0. PubMed
  81. Lu, W., Jin, T., et al. 2025. Sci Rep. 15(1),44077. PubMed
  82. Izgutdina, A., Rashid, T., et al. 2025. J Immunother Cancer. 13(12),0. PubMed
  83. Pracht K, et al. 2021. Eur J Immunol. 51:1089. PubMed
  84. Radwanska M, et al. 2020. Methods Mol Biol. 2116:721. PubMed
  85. Rendon CJ, et al. 2022. Front Endocrinol (Lausanne). 13:995499. PubMed
  86. Effern M, et al. 2022. STAR Protoc. 3:101038. PubMed
  87. Della Verde G, et al. 2022. Life Sci Alliance. 5:. PubMed
  88. Su C, et al. 2021. Front Oncol. 11:719564. PubMed
  89. Jacoby E, et al. 2021. NPJ Regen Med. 6:58. PubMed
  90. Chen Z, et al. 2020. Glia. 68:2148. PubMed
  91. Seow JJW, et al. 2021. Front Med (Lausanne). 8:603374. PubMed
  92. Herisson F, et al. 2018. Nat Neurosci. 21:1209. PubMed
  93. Shin J, et al. 2020. Hum Gene Ther. . PubMed
  94. Bouchareychas L, et al. 2021. iScience. 24(8):102847. PubMed
  95. Spengler J, et al. 2016. J Infect Dis. 214: S308 - S318. PubMed
  96. Zheng M, et al. 2016. J Immunol. 196: 4122 - 4131. PubMed
  97. St-Pierre S, et al. 2016. PLoS One. 11: 0150230. PubMed
  98. Ensan S, et al. 2015. Nat Immunol. 17: 159-168. PubMed
  99. Jaiswal M, et al. 2015. Sci Rep. 5: 15221. PubMed
  100. Hou J, et al. 2015. J Mol Cell Biol. 7: 338-350. PubMed
  101. Fujii H, et al. 2015. PLoS One. 10: 0133216. PubMed
  102. Zhang J, et al. 2021. Aging (Albany NY). 13:17880. PubMed
  103. Press AT, et al. 2021. EMBO Mol Med. 13:e14436. PubMed
  104. Sima LE, et al. 2021. J Immunother Cancer. 9:. PubMed
  105. Ma H, et al. 2021. Front Immunol. 12:760095. PubMed
  106. McGill CJ, et al. 2021. STAR Protoc. 2:100948. PubMed
  107. Lutze J, et al. 2022. Methods Mol Biol. 2394:299. PubMed
  108. Hosseini A, et al. 2022. Evid Based Complement Alternat Med. 2022:5639226. PubMed
  109. Bikorimana JP, et al. 2022. Cell Rep Med. 3:100534. PubMed
  110. Zhang L, et al. 2022. JCI Insight. 7:. PubMed
  111. Baldominos P, et al. 2022. STAR Protoc. 3:101795. PubMed
  112. Liu W, et al. 2017. Int J Environ Res Public Health. 10.3390/ijerph14060592. PubMed
  113. Pietrocola F, et al. 2017. Autophagy. 0.935416667. PubMed
  114. Chou YJ, et al. 2020. Sci Rep. 10:8422. PubMed
  115. Wang J, et al. 2020. Sci Rep. 10:12785. PubMed
  116. Ma Y, et al. 2014. Cancer Res. 74:436. PubMed
  117. Magalhães L, et al. 2015. PLoS Negl Trop Dis. 10: 0003816. PubMed
  118. Moraes-Vieira P, et al. 2016. Diabetes. 65: 1317 - 1327. PubMed
  119. Garcia-Fabiani MB, et al. 2020. STAR Protoc. :1. PubMed
  120. Chen J, et al. 2022. Nat Commun. 13:6759. PubMed
  121. Wu Y, et al. 2021. Nat Biomed Eng. 5:1336. PubMed
  122. Meng S, et al. 2022. Exp Anim. . PubMed
  123. Kokkinopoulos I, et al. 2021. Sci Rep. 11:15759. PubMed
  124. Johnson CL, et al. 2021. Am J Physiol Heart Circ Physiol. 321:H756. PubMed
  125. Stringhini M, et al. 2021. MAbs. 13:1868066. PubMed
  126. Boldin M, et al. 2011. J Exp Med. 208:1189. PubMed
  127. Sun CC, et al. 2020. Genome Med. 0.553472222. PubMed
  128. Bravo–San Pedro JM, et al. 2019. Cell Metab. 30:754. PubMed
  129. Clark EL, et al. 2017. PLoS Genet. 13:e1006997. PubMed
  130. Cantor JR, et al. 2017. Cell. 169:258. PubMed
  131. Ji WJ, et al. 2017. Cytometry B Clin Cytom. 92:371. PubMed
  132. Devalaraja S, et al. 2020. Cell. 1098:180. PubMed
  133. Elisabeth Schrumpf, Xiaojun Jiang 2017. Physiol Rep. 10.14814/phy2.13117. PubMed
  134. AC Belkina, JE Snyder-Cappione 2017. Cytometry A. 91:175-179. PubMed
  135. Brunmeir R, et al. 2016. PLoS Genet. 12:e1006474. PubMed
  136. Pridans C, et al. 2016. J Immunol. 197: 2297 - 2305. PubMed
  137. Mircheff A, et al. 2016. Ocul Surf. 14:460-483. PubMed
  138. Pennington L, et al. 2016. Nat Commun. 7:11610. PubMed
  139. Koon H, et al. 2012. J Vis Exp. 68: 4208. PubMed
  140. Zhai Z, et al. 2021. Medicine (Baltimore). 100:e26214. PubMed
  141. Hu D, et al. 2021. J Cell Mol Med. 25:2900. PubMed
  142. Jones N, et al. 2021. Nat Commun. 12:1209. PubMed
  143. Wang D, et al. 2021. Signal Transduct Target Ther. 6:376. PubMed
  144. Machado H, et al. 2021. PLoS Pathog. 17:e1009933. PubMed
  145. Yan X, et al. 2022. Int J Biol Sci. 18:585. PubMed
  146. Singh SS, et al. 2021. Eur J Med Chem. 216:113312. PubMed
  147. Pokhrel RH, et al. 2022. Int J Mol Sci. 23:. PubMed
  148. Sakamoto S, et al. 2020. OncoImmunology. 8(12):e1671760.. PubMed
  149. Rico C, et al. 2012. Carcinogenesis. 33:2283. PubMed
  150. Hamour S, et al. 2015. PLoS One. 10: 0136238. PubMed
  151. Bazett M, Haston M 2016. Sci Rep. 6:19189. PubMed
  152. Luo B, et al. 2016. J Neurosci. 36: 9590 - 9603. PubMed
  153. Patera A, et al. 2016. J Leukoc Biol. 100(6):1239-1254. PubMed
  154. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  155. Mo L, et al. 2022. Front Oncol. 12:871489. PubMed
  156. Huang L, et al. 2021. J Cell Physiol. 236:7308. PubMed
  157. Whytock KL, et al. 2022. iScience. 25:104772. PubMed
  158. Neufeld L, et al. 2021. Sci Adv. 7:. PubMed
  159. Friedman G, et al. 2020. Nat Cancer. 1:692. PubMed
  160. Kumar A, et al. 2021. Part Fibre Toxicol. 18:43. PubMed
  161. Tanaka Y, et al. 2021. Int J Mol Sci. 22:. PubMed
  162. Scherer SD, et al. 2021. Breast Cancer Res. 23:100. PubMed
  163. Jeong J, et al. 2021. Immune Netw. 21:e31. PubMed
  164. Sitaraman S, et al. 2021. JCI Insight. 6:. PubMed
  165. Orr AN, et al. 2021. Int J Mol Sci. 22:. PubMed
  166. Vannini N, et al. 2019. Cell Stem Cell. 24:405. PubMed
  167. Jiang J, et al. 2018. Cancer Med. 3.504861111. PubMed
  168. Chen Z, et al. 2017. Cancer Res. 77:2266. PubMed
  169. Kim M, et al. 2017. Int J Mol Sci. 10.3390/ijms18061275. PubMed
  170. Facchini M, et al. 2014. J Vis Exp. 85: 51019. PubMed
  171. Ilievski V, et al. 2015. PLoS One. 10: 0136502. PubMed
  172. Saraiva A, et al. 2013. Hum Immunol. 74:207. PubMed
  173. Kildisiute G, et al. 2021. Sci Adv. 7: . PubMed
  174. Schiferle EB, et al. 2021. Sci Adv. 7: . PubMed
  175. Devalaraja S, et al. 2020. STAR Protoc. 1:100188. PubMed
  176. Bigenwald C, et al. 2021. Nat Med. 27:851. PubMed
  177. Gingrich AA, et al. 2021. Front Immunol. 12:670309. PubMed
  178. Dang Y, et al. 2022. Cancer Cell Int. 22:88. PubMed
  179. Deng J, et al. 2021. Breast Cancer Res Treat. 185:85. PubMed
  180. Vivanco Gonzalez N, et al. 2022. STAR Protoc. 3:101280. PubMed
  181. Qin L, et al. 2022. Nat Commun. 13:6051. PubMed
  182. Escudero-Lara A, et al. 2022. Front Behav Neurosci. 16:946975. PubMed
  183. Wang K, et al. 2017. Molecular Immunology. 10.1016/j.molimm.2017.04.016. PubMed
  184. Appelbe O, et al. 2017. J Control Release.. 10.1016/j.jconrel.2017.09.043. PubMed
  185. Tang J, et al. 2017. Proc Natl Acad Sci U S A. 114:E7441. PubMed
  186. Liccardi G, et al. 2019. Mol Cell. 73:413. PubMed
  187. Patil R, et al. 2019. J Biomed Opt. 24:1. PubMed
  188. Ongaro T, et al. 2020. Oncotarget. 3.026388889. PubMed
  189. Kahlenberg J, et al. 2011. J Immunol. 187:6143. PubMed
  190. Han W, et al. 2013. J Immunol. 190:4786. PubMed
  191. Yamasaki S, et al. 2013. Clin Vaccine Immunol. 20:1508. PubMed
  192. Fukui R, et al. 2016. J Immunol. 196: 416 - 427. PubMed
  193. Rodriguez-Garcia M, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.72. PubMed
  194. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  195. Evans AK, et al. 2020. Neurobiol Dis. 146:105089. PubMed
  196. Martínez-Muriana A, et al. 2020. Stem Cell Res Ther. 11:53. PubMed
  197. Pennig J, et al. 2019. Sci Rep. 9:17937. PubMed
  198. Wang B, et al. 2017. Stem Cell Res Ther.. 10.1186/s13287-017-0744-6. PubMed
  199. Anstine L,et al. 2017. J Am Heart Assoc.. 10.1161/JAHA.117.007097. PubMed
  200. Judge SJ, et al. 2020. J Clin Invest. 130:3051. PubMed
  201. Choi JW, et al. 2020. PLoS One. 15:e0235518. PubMed
  202. Alban TJ, et al. 2020. Front Immunol. 1.285416667. PubMed
  203. Jiang S, et al. 2017. Toxicology Lett. 10.1016/j.toxlet.2017.03.015. PubMed
  204. Agrawal V, et al. 2016. J Leukoc Biol. 100: 261 - 274. PubMed
  205. Yu Z, et al. 2021. Front Oncol. 11:659251. PubMed
  206. Deng J, et al. 2021. Nat Cancer. 2:503. PubMed
  207. Beaudoin-Bussières G, et al. 2022. Cell Rep. 38:110368. PubMed
  208. Hu H, et al. 2021. Cancer Immunol Res. 9:1298. PubMed
  209. Zhong W, et al. 2022. Nat Commun. 13:4390. PubMed
  210. So EY, et al. 2021. Am J Physiol Cell Physiol. 321:C569. PubMed
  211. Bunting MD, et al. 2022. Sci Adv. 8:eabk3327. PubMed
  212. Elphinstone R, et al. 2017. Infect Immun. 10.1128/IAI.00371-17. PubMed
  213. Kernfeld EM, et al. 2018. Immunity. 48:1258. PubMed
  214. Nwani NG, et al. 2019. Cancers (Basel). 0.806944444. PubMed
  215. Ramalingam P, et al. 2020. Nat Commun. 11:666. PubMed
  216. Garcia-Arcos I, et al. 2013. J Biol Chem. 288:14046. PubMed
  217. Sci T 2013. Toxicol Sci. 136:72. PubMed
  218. Metz H, et al. 2016. Proc Natl Acad Sci U S A. 113: 8795 - 8800. PubMed
  219. Cheng Q, et al. 2020. Nat Nanotechnol. 0.842361111. PubMed
  220. Xie Z, et al. 2020. Light Sci Appl. 0.486805556. PubMed
  221. Alghamri MS, et al. 2020. Methods Enzymol. 632:215. PubMed
  222. Tavakol DN, et al. 2021. Curr Protoc. 1:e275. PubMed
  223. Ullah I, et al. 2021. Immunity. 54:2143. PubMed
  224. He Y, et al. 2021. Front Immunol. 12:641206. PubMed
  225. , et al. 2021. Eur J Immunol. 51:2708. PubMed
  226. Ercoli G, et al. 2022. Clin Transl Immunology. 11:e1366. PubMed
  227. Meng YM, et al. 2021. Nat Commun. 12:6011. PubMed
  228. Zhu QY, et al. 2021. Nat Commun. 12:6624. PubMed
  229. Patel M, et al. 2021. Cancer Res. 81:3985. PubMed
  230. Shi X, et al. 2021. Nat Commun. 12:2547. PubMed
  231. Mirando AC, et al. 2020. Oncoimmunology. 9:1760685. PubMed
  232. Rosenbluth JM, et al. 2020. Nat Commun. 11:1711. PubMed
  233. Ramaswamy G, et al. 2017. Sci Rep. 10.1038/srep45140. PubMed
  234. Lizotte P, et al. 2016. Sci Rep. 6:31745. PubMed
  235. Hills LB, et al. 2021. J Immunol. 206:89. PubMed
  236. Page N, et al. 2021. Nat Commun. 12:1009. PubMed
  237. Pace J, et al. 2022. J Biomed Opt. 27:. PubMed
  238. Pedicona F, et al. 2022. Sci Signal. 15:eabl7989. PubMed
  239. Fidalgo MF, et al. 2022. Life Sci Alliance. 5:. PubMed
  240. Stirling ER, et al. 2022. J Immunother Cancer. 10:. PubMed
  241. Wen J, et al. 2017. J Hematol Oncol. 10.1186/s13045-017-0489-9. PubMed
  242. Ahmad S,et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. . 10.1016/j.pnpbp.2017.10.001. PubMed
  243. Hang J, et al. 2019. Cancer Med. 1.254166667. PubMed
  244. Tan X, et al. 2019. Sci Rep. 2.7125. PubMed
  245. Lienemann PS, et al. 2020. Adv Sci (Weinh). 7:1903395. PubMed
  246. Zhao J, et al. 2013. Elife. 21:537. PubMed
  247. Weber G, et al. 2015. Surgery. 158: 248-254. PubMed
  248. Jiang H, et al. 2016. Nat Med. 10.1038/nm.4123. PubMed
  249. Elgueta R, et al. 2016. J Immunol. 197: 3970 - 3981. PubMed
  250. Sharma A, et al. 2020. Cell. 183(2):377-394.e21. PubMed
  251. Yan Q, et al. 2022. Clin Transl Med. 12:e1084. PubMed
  252. Zhai K, et al. 2021. Nat Cancer. 2:1136. PubMed
  253. Zhao D, et al. 2020. Cancer Discov. 10:1374. PubMed
  254. Schweppe RE, et al. 2019. Mol Cancer Res. 17:1036. PubMed
  255. Yamada KJ, et al. 2020. PLoS Pathog. 16:e1008354. PubMed
  256. Yang A, et al. 2018. Cancer Discov. 0.525. PubMed
  257. Rentsendorj A, et al. 2017. Brain Behav Immun. 10.1016/j.bbi.2017.08.019. PubMed
  258. Castoldi F, et al. 2020. Cell Death Discov. 0.339583333. PubMed
  259. Wang L, et al. 2020. EMBO J. 39:e104514. PubMed
  260. Morris C, et al. 2017. MBio. 10.1128/mBio.00036-17. PubMed
  261. Theurl I, et al. 2016. Nat Med. 10.1038/nm.4146. PubMed
  262. Hiza H, et al. 2021. Sci Rep. 11:13190. PubMed
  263. Ito T, et al. 2021. Nat Commun. 12:2232. PubMed
  264. Hollerbach A, et al. 2021. J Thromb Haemost. . PubMed
  265. Gamrekelashvili J, et al. 2021. Bio Protoc. 11:e4007. PubMed
  266. Yang Z, et al. 2021. Nat Commun. 12:4852. PubMed
  267. Zhang Y, et al. 2022. Vaccines (Basel). 10: . PubMed
  268. Majumdar D, et al. 2021. Curr Protoc. 1:e216. PubMed
  269. Michelotti TC, et al. 2022. Front Cell Dev Biol. 10:1025240. PubMed
  270. Ren X, et al. 2022. STAR Protoc. 3:101818. PubMed
  271. Dyck S, et al. 2018. J Neuroinflammation. 0.6875. PubMed
  272. Yang YS, et al. 2020. Mol Ther Methods Clin Dev. 17:922. PubMed
  273. Gangwar RS, et al. 2020. Sci Rep. 10:14348. PubMed
  274. Varga T, et al. 2013. J Immunol. 191:5695. PubMed
  275. Samuelson D, et al. 2016. J Immunol. 196: 2655 - 2665. PubMed
  276. Tsao P, et al. 2016. Proc Natl Acad Sci U S A. 113: 8242 - 8247. PubMed
  277. Soncini M, et al. 2016. Proc Natl Acad Sci U S A. 113: E6219 - E6227. PubMed
  278. Yang C, et al. 2016. Sci Rep. 6:34643. PubMed
  279. Nowyhed H, et al. 2017. Sci Rep. 7:40273. PubMed
  280. De Domenico E, et al. 2020. STAR Protoc. 1:100233. PubMed
  281. Wang Z, et al. 2020. Cell Rep. 33:108472. PubMed
  282. Sadik A, et al. 2020. Cell. 1252:182. PubMed
  283. Feng D, et al. 2022. Nat Commun. 13:5554. PubMed
  284. Saber M, et al. 2021. J Neurosci Res. 99:1136. PubMed
  285. Xiang Y, et al. 2022. Skelet Muscle. 12:19. PubMed
  286. Yamazaki T, et al. 2021. Oncoimmunology. 10:1962592. PubMed
  287. Gladow N, et al. 2020. PLoS One. 15:e0227734. PubMed
  288. Ramachandran P, et al. 2019. Nature. 575:512. PubMed
  289. Vasamsetti SB, et al. 2018. Immunity. 49:93. PubMed
  290. Bowers J, et al. 2017. Front Immunol. 10.3389/fimmu.2017.01221. PubMed
  291. Zhang J, et al. 2020. Pain. 161:1381. PubMed
  292. Heim CE, et al. 2020. Nature Microbiology. 5(10):1271-1284. PubMed
  293. Canali S, et al. 2017. Blood. 129(4):405-414. PubMed
  294. Shen X, et al. 2016. Sci Rep. 6:38778. PubMed
  295. Sauter K, et al. 2016. Am J Physiol Gastrointest Liver Physiol. 311: G533 - G547. PubMed
  296. Song C, et al. 2015. Blood. 126: 1813 - 1822. PubMed
  297. Sasaki Y, et al. 2015. PLoS One. 10: 0131176. PubMed
  298. Tulasi DY, et al. 2021. Cell Mol Gastroenterol Hepatol. 11:1437. PubMed
  299. Hoffmann J, et al. 2021. Nat Commun. 12:3964. PubMed
  300. Xue X, et al. 2021. Cent Eur J Immunol. 46:191. PubMed
  301. Unsinger J, et al. 2021. J Leukoc Biol. 109:697. PubMed
  302. Yang YS, et al. 2022. Nat Commun. 13:6175. PubMed
  303. Ansari M, et al. 2017. Cell Signal. 10.1016/j.cellsig.2017.04.014. PubMed
  304. Ahmad S, et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. 10.1016/j.pnpbp.2017.06.034. PubMed
  305. Bichsel C, et al. 2017. Sci Rep. 10.1038/s41598-017-09928-1. PubMed
  306. James M, et al. 2017. J Nucl Med. . 10.2967/jnumed.117.189597. PubMed
  307. Annibaldi A, et al. 2018. Mol Cell. 69:566. PubMed
  308. Hill SJ, et al. 2018. Cancer Discov. 1.308333333. PubMed
  309. Ma D, et al. 2013. J Virol. 87:3361. PubMed
  310. Kraft P, et al. 2013. Stroke. 44:3202. PubMed
  311. Kim M, et al. 2014. Mol Pharmacol. 86:284. PubMed
  312. Cekic C, et al. 2014. Cancer Res. 74:7250. PubMed
  313. Pankova D, et al. 2016. Mol Cancer Res. 14: 287 - 295. PubMed
  314. Kobia FM, et al. 2020. PLoS Biol. 18:e3000850. PubMed
  315. Li N, et al. 2022. Nat Commun. 13:7281. PubMed
  316. Soileau AM, et al. 2022. Vet Sci. 9:. PubMed
  317. McClellan BL, et al. 2022. STAR Protoc. 3:101357. PubMed
  318. Governa V, et al. 2022. Proc Natl Acad Sci U S A. 119. PubMed
  319. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  320. Mai CL, et al. 2021. Theranostics. 11:1059. PubMed
  321. Chen P, et al. 2021. Clin Transl Med. 11:e462. PubMed
  322. Resende M, et al. 2010. Physiol Genomics. 42:437. PubMed
  323. McLaughlin S, et al. 2019. Nat Commun. 3.795833333. PubMed
  324. Koury J, et al. 2019. PLoS One. 14:e0218670. PubMed
  325. Zhang Z, et al. 2017. Journal of Translational Medicine. 10.1186/s12967-017-1196-6. PubMed
  326. Peng X, et al. 2021. Stem Cell Res Ther. 198:12. PubMed
  327. Linder A, et al. 2020. EMBO J. 39:e105071. PubMed
  328. Muñoz-Ruiz M, et al. 2016. Nat Immunol. 10.1038/ni.3424. PubMed
  329. Chang Y, et al. 2014. Cytotherapy. 16:560. PubMed
  330. Hsia B, et al. 2012. J Allergy Clin Immunol. 130:205. PubMed
  331. Cordo' V, et al. 2022. Nat Commun. 13:1048. PubMed
  332. Hallisey M, et al. 2022. STAR Protoc. 3:101163. PubMed
  333. Denoth-Lippuner A, et al. 2021. Cell Stem Cell. 28:2020. PubMed
  334. Maas RR, et al. 2021. Nat Protoc. 16:4692. PubMed
  335. Nagree MS, et al. 2022. EMBO Mol Med. 14:e14297. PubMed
  336. Sobecki M, et al. 2022. Cell Stem Cell. 29:1459. PubMed
  337. Mochizuki M,et al. 2017. J Am Heart Assoc. . 10.1161/JAHA.117.005920. PubMed
  338. Roh–Johnson M, et al. 2017. Dev Cell. 43:549. PubMed
  339. Müller C, et al. 2018. Elife. 7:e34985. PubMed
  340. Guo W, et al. 2013. J Gerontol A Biol Sci Med Sci. . PubMed
  341. Liu Y, et al. 2015. Sci Rep. 5: 15134. PubMed
  342. Hodson D, et al. 2016. Proc Natl Acad Sci U S A. 113: 2039-2046. PubMed
  343. Munson D, et al. 2016. Proc Natl Acad Sci U S A. 113: 8272 - 8277. PubMed
  344. Ubellacker J, et al. 2017. Breast Cancer Res. 10.1186/s13058-017-0815-8. PubMed
  345. DU T, et al. 2020. Front Immunol. 1.571527778. PubMed
  346. Trial J, et al. 2020. Geroscience. . PubMed
  347. Visweshwaran SP, et al. 2022. Front Cell Dev Biol. 10:1008898. PubMed
  348. Li Q, et al. 2022. Signal Transduct Target Ther. 7:222. PubMed
  349. Fielding C, et al. 2022. Nat Commun. 13:543. PubMed
  350. Vechetti IJ, et al. 2021. FASEB J. 35:e21644. PubMed
  351. Denning W, et al. 2011. PLoS One. 6:e16897. PubMed
  352. Weaver J, et al. 2017. Part Fibre Toxicol. 10.1186/s12989-017-0206-4. PubMed
  353. Samuelson D, et al. 2017. PLoS Pathogens. 13(6):e1006426. PubMed
  354. Wong C, et al. 2017. J Immunol. 10.4049/jimmunol.1700397. PubMed
  355. Saber M, et al. 2020. Eur J Neurosci. 52:2791. PubMed
  356. Wu R, et al. 2020. J Immunother Cancer. 8:00. PubMed
  357. Yu H, et al. 2016. Sci Rep. 6:35190. PubMed
  358. Now H, Yoo J 2016. Cell Mol Immunol. 10.1038/cmi.2016.32. PubMed
  359. Bosma M, et al. 2016. Nat Commun. 7: 11314. PubMed
  360. YC S, SJ L 2015. Sci Rep. 5: 12578. PubMed
  361. Szulzewsky F, et al. 2015. PLoS One. 10:116644. PubMed
  362. Wu C, et al. 2012. PLoS One. 7:e42363. PubMed
  363. Barcia Durán JG, et al. 2021. Commun Biol. 4:406. PubMed
  364. Park HJ, et al. 2021. Int J Mol Sci. 22:. PubMed
  365. Cebrian-Silla A, et al. 2021. Elife. 10:. PubMed
  366. Yeini E, et al. 2021. Nat Commun. 12:1912. PubMed
  367. Wang X, et al. 2021. Sci Transl Med. 13:. PubMed
  368. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  369. Kucykowicz S, et al. 2022. STAR Protoc. 3:101356. PubMed
  370. Kim TW, et al. 2022. Mol Ther Oncolytics. 26:1. PubMed
  371. Kathania M, et al. 2022. Cell Rep. 40:111345. PubMed
  372. Shaashua L, et al. 2022. Nat Commun. 13:6513. PubMed
  373. Gupta R, et al. 2020. Cell Stem Cell. 26:527. PubMed
  374. Roybal J, et al. 2011. Mol Cancer Res. 9:25. PubMed
  375. Cekic C, et al. 2013. J Exp Med. 210:2693. PubMed
  376. Roy IM, et al. 2021. Bio Protoc. 11:e4130. PubMed
  377. Alam A, et al. 2022. STAR Protoc. 3:101563. PubMed
  378. Xiang Y, et al. 2022. Exp Mol Med. 54:1011. PubMed
  379. Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed
  380. Guo P, et al. 2022. Nat Cell Biol. 24:99. PubMed
  381. Wahane S, et al. 2021. Sci Adv. 7:. PubMed
  382. Xie Z, et al. 2020. Light Sci Appl. 9:161. PubMed
  383. Huang N, et al. 2021. Nat Med. 27:892. PubMed
  384. Song X, et al. 2021. FEBS Open Bio. 11:2453. PubMed
  385. Field-Corbett C, et al. 2009. Stem Cells. 27:662. PubMed
  386. Zeng Y, et al. 2019. FASEB J. 33:6596. PubMed
  387. Zheng W, et al. 2019. Cell Rep. 29:1747. PubMed
  388. Tomas C, et al. 2019. Sci Rep. 9:11464. PubMed
  389. Kim JK, et al. 2019. Bioengineering (Basel). 6:24. PubMed
  390. Alizadeh A, et al. 2018. J Neuroinflammation. 15:53. PubMed
  391. Guo P, et al. 2017. J Clin Invest. 127:4242. PubMed
  392. Tsai SC, et al. 2017. Biomicrofluidics. 11:034122. PubMed
  393. Chen S, et al. 2020. Cancer Immunol Res. 1064:8. PubMed
  394. Erady C, et al. 2021. NPJ Genom Med. 6:04. PubMed
  395. de Silva S, et al. 2020. Cancer Immunol Res. 0.493055556. PubMed
  396. Wan C, et al. 2021. Cancer Res. 81:158. PubMed
  397. Wang X, et al. 2016. J Virol. 90: 10247 - 10258. PubMed
  398. Mohammed R, et al. 2016. Cell Rep. 14:760-771. PubMed
  399. Durward-Diioia M, et al. 2015. Infect Immun . 83: 4759 - 4771. PubMed
  400. Birnie K, et al. 2015. Mol Cancer Res. 13: 1106 - 1118. PubMed
  401. Liu X, et al. 2013. Invest Ophthalmol Vis Sci . 54:7386. PubMed

Antigen Details

Cell Type
Tregs
Gene ID
NA

Related FAQs

There are no FAQs for this product.
Go To Top Version: 3    Revision Date: 06/10/2022

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account